Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.55 |
| ▸ | CTSS | P25774 | 7/20 | 0.50 |
| ▸ | GRN | P28799 | 2/20 | 0.50 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.50 |
| ▸ | CTSL | P07711 | 5/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CTSB | P07858 | 2/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | CCKBR | P32239 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7289965 | 0.89 | MEN1 (0.50) | CPB2CTSSGRNSORT1CTSL | |
| SCHEMBL6876245 | 0.88 | CTSS (0.64) | CPB2CTSSGRNSORT1CTSL | |
| SCHEMBL7297694 | 0.87 | CTSS (0.48) | CPB2CTSSGRNSORT1CTSL | |
| SCHEMBL9124964 | 0.87 | CPB2 (0.45) | CPB2CTSSGRNSORT1CTSL | |
| SCHEMBL7297681 | 0.87 | CTSS (0.48) | CPB2CTSSGRNSORT1CTSL | |
| Lithium Ion SCHEMBL5521688 | 0.85 | CTSS (0.48) | CPB2CTSSCTSLPOLBHTT | |
| SCHEMBL6876113 | 0.84 | ALDH1A1 (0.50) | CPB2CTSSGRNSORT1CTSL | |
| SCHEMBL6592042 | 0.82 | CTSS (0.49) | CPB2CTSSGRNSORT1CTSL | |
| SCHEMBL6879172 | 0.82 | CTSS (0.49) | CPB2CTSSGRNSORT1CTSL | |
| SCHEMBL5523061 | 0.81 | CTSS (0.62) | CPB2CTSSCTSLCTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1452522-A2 | Novel compounds and compositions as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2004-09-01 | — | — | EP | disclosed |